FSD Pharma and SciCann Therapeutics Launch Cardiovascular Research Program in Tel Aviv University

Cannabis Business Times
Sep 24, 2018, 2:16 pm99 pts
Toronto – September 23, 2018/CNW/ – PRESS RELEASE – FSD Pharma Inc. has announced the launch of a comprehensive sponsored research program in Tel Aviv University together with its strategic R&D partner, SciCann Therapeutics Inc., focused on the cardiovascular disease field. The new research program is aimed at…

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Hemp Needs What Alcohol Already Has: A Clear Definition (Op-Ed) 71

Ohio Lawmakers Planning to Pass Intoxicating Hemp Law Before Thanksgiving 68

Missouri Officials Propose Tightening Cannabis Licensing Rules 53

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.